Detailed analysis of the genetic characteristics of a child’s tumour can provide doctors with lots of information about the tumour and how best to treat it. This is known as precision medicine, and this project aims to put in place the infrastructure necessary to introduce the systematic testing of newly diagnosed and relapsed children.
Our funding is enabling doctors to develop brand new ways of analysing tumours and treating them. It’s also introducing an improved approach to the testing of newly diagnosed and relapsed children.
This research project on introducing the systematic testing of newly diagnosed and relapsed children has been successfully completed. Your donations allow us to fund ground-breaking research that can improve treatments given to children with cancer. Thank you. Your help allows us to continue to find ways to drive up the chances of survival for children with cancer and reduce the toxic side effects that can affect the rest of their lives.
Molecularly Guided Treatment in Childhood Cancer
Professor Louis Chesler
The Institute of Cancer Research
Sutton SM2 5NG
1 October 2016